Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli.

Caetano T, Krawczyk JM, Mösker E, Süssmuth RD, Mendo S.

Chem Biol. 2011 Jan 28;18(1):90-100. doi: 10.1016/j.chembiol.2010.11.010.

2.

Engineering the heterologous expression of lanthipeptides in Escherichia coli by multigene assembly.

Kuthning A, Mösker E, Süssmuth RD.

Appl Microbiol Biotechnol. 2015 Aug;99(15):6351-61. doi: 10.1007/s00253-015-6557-6.

PMID:
25846334
3.

Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13.

Dischinger J, Josten M, Szekat C, Sahl HG, Bierbaum G.

PLoS One. 2009 Aug 26;4(8):e6788. doi: 10.1371/journal.pone.0006788.

4.

Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.

Nagao J, Aso Y, Shioya K, Nakayama J, Sonomoto K.

J Mol Microbiol Biotechnol. 2007;13(4):235-42.

PMID:
17827974
5.
6.

Lichenicidin biosynthesis in Escherichia coli: licFGEHI immunity genes are not essential for lantibiotic production or self-protection.

Caetano T, Krawczyk JM, Mösker E, Süssmuth RD, Mendo S.

Appl Environ Microbiol. 2011 Jul;77(14):5023-6. doi: 10.1128/AEM.00270-11.

7.

Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids.

Oldach F, Al Toma R, Kuthning A, Caetano T, Mendo S, Budisa N, Süssmuth RD.

Angew Chem Int Ed Engl. 2012 Jan 9;51(2):415-8. doi: 10.1002/anie.201106154.

PMID:
22128014
8.

Expression of the lantibiotic mersacidin in Bacillus amyloliquefaciens FZB42.

Herzner AM, Dischinger J, Szekat C, Josten M, Schmitz S, Yakéléba A, Reinartz R, Jansen A, Sahl HG, Piel J, Bierbaum G.

PLoS One. 2011;6(7):e22389. doi: 10.1371/journal.pone.0022389.

9.

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

Begley M, Cotter PD, Hill C, Ross RP.

Appl Environ Microbiol. 2009 Sep;75(17):5451-60. doi: 10.1128/AEM.00730-09.

10.

Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides.

Basi-Chipalu S, Dischinger J, Josten M, Szekat C, Zweynert A, Sahl HG, Bierbaum G.

Appl Environ Microbiol. 2015 May 15;81(10):3419-29. doi: 10.1128/AEM.00299-15.

11.

Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21.

Shenkarev ZO, Finkina EI, Nurmukhamedova EK, Balandin SV, Mineev KS, Nadezhdin KD, Yakimenko ZA, Tagaev AA, Temirov YV, Arseniev AS, Ovchinnikova TV.

Biochemistry. 2010 Aug 3;49(30):6462-72. doi: 10.1021/bi100871b.

PMID:
20578714
12.

Impact of domestication in the production of the class II lanthipeptide lichenicidin by Bacillus licheniformis I89.

Caetano T, Süssmuth RD, Mendo S.

Curr Microbiol. 2015 Mar;70(3):364-8. doi: 10.1007/s00284-014-0727-0.

PMID:
25399299
13.

The biology of lantibiotics from the lacticin 481 group is coming of age.

Dufour A, Hindré T, Haras D, Le Pennec JP.

FEMS Microbiol Rev. 2007 Mar;31(2):134-67. Review.

14.

Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.

Szekat C, Jack RW, Skutlarek D, Färber H, Bierbaum G.

Appl Environ Microbiol. 2003 Jul;69(7):3777-83.

15.

Lantibiotics: mode of action, biosynthesis and bioengineering.

Bierbaum G, Sahl HG.

Curr Pharm Biotechnol. 2009 Jan;10(1):2-18. Review.

PMID:
19149587
16.

Bioengineering of lanthipeptides in Escherichia coli: assessing the specificity of lichenicidin and haloduracin biosynthetic machinery.

Caetano T, Barbosa J, Möesker E, Süssmuth RD, Mendo S.

Res Microbiol. 2014 Sep;165(7):600-4. doi: 10.1016/j.resmic.2014.07.006.

PMID:
25058408
17.

Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster.

Heidrich C, Pag U, Josten M, Metzger J, Jack RW, Bierbaum G, Jung G, Sahl HG.

Appl Environ Microbiol. 1998 Sep;64(9):3140-6.

18.

Characterization of amylolysin, a novel lantibiotic from Bacillus amyloliquefaciens GA1.

Arguelles Arias A, Ongena M, Devreese B, Terrak M, Joris B, Fickers P.

PLoS One. 2013 Dec 9;8(12):e83037. doi: 10.1371/journal.pone.0083037.

19.

Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster.

Altena K, Guder A, Cramer C, Bierbaum G.

Appl Environ Microbiol. 2000 Jun;66(6):2565-71.

20.

Protein engineering of lantibiotics.

Kuipers OP, Bierbaum G, Ottenwälder B, Dodd HM, Horn N, Metzger J, Kupke T, Gnau V, Bongers R, van den Bogaard P, Kosters H, Rollema HS, de Vos WM, Siezen RJ, Jung G, Götz F, Sahl HG, Gasson MJ.

Antonie Van Leeuwenhoek. 1996 Feb;69(2):161-69. Review.

PMID:
8775976
Items per page

Supplemental Content

Support Center